NL8403195A - Immunogene complexen en vaccins die deze bevatten. - Google Patents

Immunogene complexen en vaccins die deze bevatten. Download PDF

Info

Publication number
NL8403195A
NL8403195A NL8403195A NL8403195A NL8403195A NL 8403195 A NL8403195 A NL 8403195A NL 8403195 A NL8403195 A NL 8403195A NL 8403195 A NL8403195 A NL 8403195A NL 8403195 A NL8403195 A NL 8403195A
Authority
NL
Netherlands
Prior art keywords
protein
detergent
purified
complexes
proteins
Prior art date
Application number
NL8403195A
Other languages
English (en)
Dutch (nl)
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Priority to NL8403195A priority Critical patent/NL8403195A/nl
Priority to EP85201657A priority patent/EP0182401B1/en
Priority to AT85201657T priority patent/ATE44651T1/de
Priority to DE8585201657T priority patent/DE3571551D1/de
Priority to CA000493281A priority patent/CA1251396A/en
Priority to JP60233152A priority patent/JPS61171432A/ja
Publication of NL8403195A publication Critical patent/NL8403195A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NL8403195A 1984-10-19 1984-10-19 Immunogene complexen en vaccins die deze bevatten. NL8403195A (nl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
NL8403195A NL8403195A (nl) 1984-10-19 1984-10-19 Immunogene complexen en vaccins die deze bevatten.
EP85201657A EP0182401B1 (en) 1984-10-19 1985-10-10 Vaccines comprising immunogenic protein or peptide complexes
AT85201657T ATE44651T1 (de) 1984-10-19 1985-10-10 Immunogene protein- oder peptidkomplexe enthaltende vakzine.
DE8585201657T DE3571551D1 (en) 1984-10-19 1985-10-10 Vaccines comprising immunogenic protein or peptide complexes
CA000493281A CA1251396A (en) 1984-10-19 1985-10-18 Vaccines comprising immunogenic protein or peptide complexes
JP60233152A JPS61171432A (ja) 1984-10-19 1985-10-18 免疫原性蛋白質またはペプチド複合体からなるワクチン

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8403195A NL8403195A (nl) 1984-10-19 1984-10-19 Immunogene complexen en vaccins die deze bevatten.
NL8403195 1984-10-19

Publications (1)

Publication Number Publication Date
NL8403195A true NL8403195A (nl) 1986-05-16

Family

ID=19844639

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8403195A NL8403195A (nl) 1984-10-19 1984-10-19 Immunogene complexen en vaccins die deze bevatten.

Country Status (6)

Country Link
EP (1) EP0182401B1 (ja)
JP (1) JPS61171432A (ja)
AT (1) ATE44651T1 (ja)
CA (1) CA1251396A (ja)
DE (1) DE3571551D1 (ja)
NL (1) NL8403195A (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68918189T2 (de) 1988-06-29 1995-01-12 Univ Rockefeller Neisseria-Vakzine.
US7118757B1 (en) 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
WO1993003762A1 (en) * 1991-08-13 1993-03-04 Biotech Australia Pty. Limited Immunostimulation
AU656414B2 (en) * 1991-08-13 1995-02-02 Biotech Australia Pty Limited Immunostimulation
DE69423383T2 (de) 1993-05-13 2000-08-24 American Cyanamid Co Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
IL148672A0 (en) * 1999-09-24 2002-09-12 Smithkline Beecham Biolog Use of combination of polyxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
US20030108565A1 (en) * 2001-07-10 2003-06-12 Johnson Mark E. Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2446111A1 (fr) * 1979-01-12 1980-08-08 Hours Michel Procede de preparation d'antigenes et vaccins obtenus selon ce procede
DE3014189A1 (de) * 1980-04-14 1981-10-15 Europäisches Laboratorium für Molekularbiologie (EMBL), 6900 Heidelberg Verfahren zur herstellung eines immunogenen membranproteinaggregats von influenza-, parainfluenza- und rhabdo-viren
WO1983003354A1 (en) * 1982-03-30 1983-10-13 Us Army Neisseria gonorrhoeae vaccine
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin

Also Published As

Publication number Publication date
DE3571551D1 (en) 1989-08-24
ATE44651T1 (de) 1989-08-15
EP0182401B1 (en) 1989-07-19
EP0182401A1 (en) 1986-05-28
JPS61171432A (ja) 1986-08-02
CA1251396A (en) 1989-03-21

Similar Documents

Publication Publication Date Title
Frasch et al. An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity
Ferrari et al. Outer membrane vesicles from group B Neisseria meningitidis Δgna33 mutant: Proteomic and immunological comparison with detergent‐derived outer membrane vesicles
US4707543A (en) Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines
Alberti et al. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins
AU2005316864B2 (en) Glycoconjugate vaccines containing peptidoglycan
Danve et al. Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals
US4753796A (en) Process for obtaining protein-polysaccharide complexes involving precipitation with quaternary ammonium salts
Kuusi et al. Immunization with major outer membrane protein (porin) preparations in experimental murine salmonellosis: effect of lipopolysaccharide
KR880001098B1 (ko) 헤모필루스 인플루엔재 b 다당류 엑소톡소이드 배합체 왁진의 제조방법
KR910002553B1 (ko) 폴리삭카라이드-단백질 결합체 및 이의 제조방법
AU594400B2 (en) Major iron-regulated protein of neisseria gonorrhoeae and its use as vaccine
US20090258397A1 (en) METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SEROTYPES A, C, Y, and W-135
HU219672B (hu) Eljárás egy patogén ágensből nyert antigén poliszacharidból származó oligoszacharid előállítására
HU218146B (hu) Továbbfejlesztett meningokokkusz-poliszacharid-konjugátum vakcina
Mandrell et al. Complement-mediated bactericidal activity of human antibodies to poly α2→ 8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B
Moreno et al. Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide
Garner et al. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide
Inzana Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5
NL8403195A (nl) Immunogene complexen en vaccins die deze bevatten.
Merino et al. Mesophilic Aeromonas sp. serogroup O: 11 resistance to complement-mediated killing
WO2006026689A2 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
Meister et al. Role of Candida albicans in granulomatous tissue reactions. I. In vitro degradation of C. albicans and immunospecificity of split products
Lugowski et al. Enterobacterial common antigen-tetanus toxoid conjugate as immunogen
Pier et al. Further purification and characterization of high-molecular-weight polysaccharide from Pseudomonas aeruginosa
EP0238739B1 (en) Klebsiella capsular polysaccharide vaccine

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed